CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | Bhanji Muna Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-06-15 | Cadoret-Manier Onaiza Director | Grant or award | +12,755 | 110,150 | ||
| 2023-06-15 | Cadoret-Manier Onaiza Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-06-15 | Rodgers Richard J Director | Grant or award | +18,494 | 238,320 | ||
| 2023-06-15 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-06-15 | Bertrand William C JR Director | Grant or award | +16,581 | 218,743 | ||
| 2023-06-15 | Bertrand William C JR Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-06-15 | MOTT DAVID M Director | Grant or award | +25,510 | 1,192,275 | ||
| 2023-06-15 | MOTT DAVID M Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-06-15 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +49,237 | 49,237 | ||
| 2023-05-23 | Felsch Robert Ora | Sale | −1,046 | $3.65 | $4K | 116,158 |
| 2023-05-23 | RAAB MICHAEL President & CEO | Sale | −11,357 | $3.65 | $41K | 887,655 |
| 2023-05-23 | GRAMMER ELIZABETH A | Sale | −2,384 | $3.65 | $9K | 330,451 |
| 2023-05-23 | Blanks Robert | Sale | −2,835 | $3.65 | $10K | 266,134 |
| 2023-05-23 | Renz Justin A Chief Financial Officer | Sale | −2,873 | $3.65 | $10K | 336,733 |
| 2023-05-23 | Rodriguez Susan Chief Commercial Officer | Sale | −4,711 | $3.65 | $17K | 353,420 |
| 2023-05-23 | Rosenbaum David P. Chief Development Officer | Sale | −2,835 | $3.65 | $10K | 372,765 |
| 2023-05-23 | Rosenbaum David P. Chief Development Officer | Sale | −934 | $3.65 | $3K | 112,162 |
| 2023-05-23 | Williams Laura A Chief Medical Officer | Sale | −2,583 | $3.65 | $9K | 319,430 |
| 2023-03-29 | Rosenbaum David P. Chief Development Officer | Sale | −3,000 | $4.63 | $14K | 113,096 |
Page 20 of 38 · 756 trades